|
|
|
|
|
|
|
|
|
|
|
| Category |
Health: Pharmacy
|
|
|
|
|
|
|
| Contact |
555 8th Avenue
Suite 310
New York, NY 10018
|
|
|
|
|
|
| Description |
The Orphan Products Regulations were issues in 1992, but Orphan Product Development has hardly been static:
* What has changed and what should sponsors be aware of as they are developing products for rare diseases?
* Especially where the numbers of patients studied has been small, what are the subsequent cost issues with requirements for more stringent follow-up of adverse events?
* If a drug product is used in a small population how can costs be contained and reimbursement be obtained?
* What companies wish to become involved in rare disease drug development?
* Why do large or small companies become involved?
* What impact is seen by the emergence of personalized medicine?
|
|
| Additional Information |
5 Easy Ways to Register
Mail: ExL Events, Inc., 555 8th Ave.,
Ste. 310, New York, NY 10018
Email: register@exlpharma.com
Phone: 866-207-6528
Fax: 888-221-6750
Online: www.exlpharma.com
INDIVIDUAL ACCESS PASS
Log-In allowing one viewer:
Register before April 17th for Early Bird Pricing: $295
Register after April 17th for Standard Pricing: $395
GROUP SITE PASS
Log-in allowing multiple viewers to join the webinar at one location: $1495
|
|
